Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 343

1.

Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.

Dubey D, Kothapalli N, McKeon A, Flanagan EP, Lennon VA, Klein CJ, Britton JW, So E, Boeve BF, Tillema JM, Sadjadi R, Pittock SJ.

J Neuroimmunol. 2018 Oct 15;323:62-72. doi: 10.1016/j.jneuroim.2018.07.009. Epub 2018 Jul 25.

PMID:
30196836
2.

LGI1 and CASPR2 Neurological Autoimmunity in Children.

Sebastian Lopez-Chiriboga A, Klein C, Zekeridou A, McKeon A, Dubey D, Flanagan EP, Lennon VA, Tillema JM, Wirrell EC, Patterson MC, Gadoth A, Gregory Aaen J, Nicholas Brenton J, Bui JD, Moen A, Otten C, Piquet A, Pittock SJ.

Ann Neurol. 2018 Aug 3. doi: 10.1002/ana.25310. [Epub ahead of print]

PMID:
30076629
3.

Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues and Outcome.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ.

Am J Ophthalmol. 2018 Jul 26. pii: S0002-9394(18)30401-X. doi: 10.1016/j.ajo.2018.07.020. [Epub ahead of print]

PMID:
30055153
4.

Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.

JAMA Neurol. 2018 Jul 16. doi: 10.1001/jamaneurol.2018.1814. [Epub ahead of print]

PMID:
30014148
5.

Autoimmune septin-5 cerebellar ataxia.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 9;5(5):e474. doi: 10.1212/NXI.0000000000000474. eCollection 2018 Sep.

6.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
7.

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):646-650. doi: 10.1002/acn3.561. eCollection 2018 May.

8.

Mutated cancer autoantigen implicated cause of paraneoplastic myasthenia gravis.

Zekeridou A, Griesmann GE, Lennon VA.

Muscle Nerve. 2018 May 9. doi: 10.1002/mus.26166. [Epub ahead of print]

PMID:
29742813
9.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Apr 28. pii: S0161-6420(18)30240-9. doi: 10.1016/j.ophtha.2018.03.041. [Epub ahead of print]

PMID:
29716788
10.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

11.

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association.

Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e418. doi: 10.1212/NXI.0000000000000418. eCollection 2018 Jan. No abstract available.

12.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

PMID:
29293273
13.

Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting.

Zalewski N, Lennon VA, Pittock SJ, Mckeon A.

Muscle Nerve. 2017 Dec 22. doi: 10.1002/mus.26053. [Epub ahead of print]

PMID:
29272039
14.

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ.

Neurology. 2018 Jan 9;90(2):e103-e110. doi: 10.1212/WNL.0000000000004803. Epub 2017 Dec 8.

PMID:
29222126
15.

Genetic variation in statin intolerance and a possible protective role for UGT1A1.

V Willrich MA, Kaleta EJ, Bryant SC, Spears GM, Train LJ, Peterson SE, Lennon VA, Kopecky SL, Baudhuin LM.

Pharmacogenomics. 2018 Jan;19(2):83-94. doi: 10.2217/pgs-2017-0146. Epub 2017 Dec 6.

PMID:
29210320
16.

Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men.

Linnoila J, Guo Y, Gadoth A, Raghunathan A, Parks B, McKeon A, Lucchinetti CF, Lennon VA, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1116-1117. doi: 10.1136/jnnp-2017-316829. Epub 2017 Nov 15. No abstract available.

PMID:
29142142
17.

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.

18.

Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.

Shimizu F, Schaller KL, Owens GP, Cotleur AC, Kellner D, Takeshita Y, Obermeier B, Kryzer TJ, Sano Y, Kanda T, Lennon VA, Ransohoff RM, Bennett JL.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaai9111. doi: 10.1126/scitranslmed.aai9111.

19.

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ.

Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979.

PMID:
28628235
20.

Predictive models in the diagnosis and treatment of autoimmune epilepsy.

Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A.

Epilepsia. 2017 Jul;58(7):1181-1189. doi: 10.1111/epi.13797. Epub 2017 May 26.

21.

Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.

Hinson SR, Clift IC, Luo N, Kryzer TJ, Lennon VA.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):5491-5496. doi: 10.1073/pnas.1701960114. Epub 2017 May 1.

22.

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.

Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF.

Acta Neuropathol. 2017 Apr;133(4):597-612. doi: 10.1007/s00401-017-1682-1. Epub 2017 Feb 9.

23.

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A.

Ann Neurol. 2017 Feb;81(2):298-309. doi: 10.1002/ana.24881.

PMID:
28120349
24.

Microtubule-associated protein 1B: Novel paraneoplastic biomarker.

Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ.

Ann Neurol. 2017 Feb;81(2):266-277. doi: 10.1002/ana.24872.

PMID:
28074593
25.

Effects of neuromyelitis optica-IgG at the blood-brain barrier in vitro.

Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E, Sano Y, Kryzer TJ, Lennon VA, Kanda T, Ransohoff RM.

Neurol Neuroimmunol Neuroinflamm. 2016 Dec 19;4(1):e311. doi: 10.1212/NXI.0000000000000311. eCollection 2017 Jan.

26.

A comparison of tissue-based and recombinant protein-based assays for detecting PCA-Tr/DNER-IgG.

Alfugham N, Roforth M, Komorowski L, Ott A, Meyer W, Probst C, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e294. eCollection 2016 Dec. No abstract available.

27.

Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients.

Zekeridou A, Lennon VA.

Brain. 2016 Oct;139(Pt 10):2581-2583. No abstract available.

PMID:
27671026
28.

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.

Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA.

JAMA Neurol. 2016 Nov 1;73(11):1297-1307. doi: 10.1001/jamaneurol.2016.2549.

PMID:
27618707
29.

Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy.

Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ.

Muscle Nerve. 2017 Apr;55(4):520-525. doi: 10.1002/mus.25371. Epub 2017 Feb 13.

PMID:
27511450
30.

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.

Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e231. doi: 10.1212/NXI.0000000000000231. eCollection 2016 Jun.

31.

Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.

Zekeridou A, McKeon A, Lennon VA.

JAMA Neurol. 2016 Jul 1;73(7):853-9. doi: 10.1001/jamaneurol.2016.0603.

PMID:
27135398
32.

Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.

Hinson SR, Lennon VA, Pittock SJ.

Handb Clin Neurol. 2016;133:377-403. doi: 10.1016/B978-0-444-63432-0.00021-9. Review.

PMID:
27112688
33.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, Sauver JS, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Robinson AB, Pittock SJ.

Ann Neurol. 2016 May;79(5):775-783. doi: 10.1002/ana.24617. Epub 2016 Apr 4.

34.

An Autoimmune Basis for Diabetes-Related Chorea?

Zekeridou A, Lennon VA.

J Child Neurol. 2016 Jun;31(7):943. doi: 10.1177/0883073815627861. Epub 2016 Jan 29. Review. No abstract available.

PMID:
26825928
35.

P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments.

Zalewski NL, Lennon VA, Lachance DH, Klein CJ, Pittock SJ, Mckeon A.

Muscle Nerve. 2016 Aug;54(2):220-7. doi: 10.1002/mus.25027. Epub 2016 Feb 8.

36.

Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity.

Bradshaw MJ, Pawate S, Lennon VA, Bloch KC, Brown KM.

Neurology. 2015 Dec 15;85(24):2176-7. doi: 10.1212/WNL.0000000000002218. Epub 2015 Nov 13. No abstract available.

37.

Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy.

Apiwattanakul M, Milone M, Pittock SJ, Kryzer TJ, Fryer JP, O'toole O, Mckeon A, Lennon VA.

Muscle Nerve. 2016 Jun;53(6):925-32. doi: 10.1002/mus.24970. Epub 2016 Feb 5.

38.

A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers.

Rinz CJ, Lennon VA, James F, Thoreson JB, Tsai KL, Starr-Moss AN, Humphries HD, Guo LT, Palmer AC, Clark LA, Shelton GD.

Neuromuscul Disord. 2015 Dec;25(12):921-7. doi: 10.1016/j.nmd.2015.09.005. Epub 2015 Sep 8.

PMID:
26429099
39.

Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.

Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M.

JAMA Neurol. 2015 Sep;72(9):996-1003. doi: 10.1001/jamaneurol.2015.1207.

PMID:
26192196
40.

Aquaporin-4 autoimmunity.

Zekeridou A, Lennon VA.

Neurol Neuroimmunol Neuroinflamm. 2015 May 21;2(4):e110. doi: 10.1212/NXI.0000000000000110. eCollection 2015 Aug. Review.

41.

Animal extremists' threats to neurologic research continue: Neuroreality II.

Beversdorf DQ, Roos RP, Hauser WA, Lennon VA, Mehler MF.

Neurology. 2015 Aug 25;85(8):730-4. doi: 10.1212/WNL.0000000000001764. Epub 2015 Jul 8. Review. No abstract available.

42.

Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.

Kruse JL, Lapid MI, Lennon VA, Klein CJ, Toole OO, Pittock SJ, Strand EA, Frye MA, McKeon A.

Psychosomatics. 2015 May-Jun;56(3):227-41. doi: 10.1016/j.psym.2015.01.003. Epub 2015 Feb 4.

PMID:
25975857
43.

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.

Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF.

Neurology. 2015 Jan 13;84(2):148-58. doi: 10.1212/WNL.0000000000001126. Epub 2014 Dec 10.

44.

Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.

Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ.

JAMA Neurol. 2015 Jan;72(1):81-7. doi: 10.1001/jamaneurol.2014.2137.

45.

Comment on "Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2".

Fang B, Lennon VA.

J Immunol. 2014 Nov 15;193(10):4755. doi: 10.4049/jimmunol.1402224. No abstract available.

46.

AQP4 autoantibody assay performance in clinical laboratory service.

Fryer JP, Lennon VA, Pittock SJ, Jenkins SM, Fallier-Becker P, Clardy SL, Horta E, Jedynak EA, Lucchinetti CF, Shuster EA, Weinshenker BG, Wingerchuk DM, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2014 May 22;1(1):e11. doi: 10.1212/NXI.0000000000000011. eCollection 2014 Jun.

47.

DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A.

Neurology. 2014 Nov 11;83(20):1797-803. doi: 10.1212/WNL.0000000000000991. Epub 2014 Oct 15.

48.

The neurologic significance of celiac disease biomarkers.

McKeon A, Lennon VA, Pittock SJ, Kryzer TJ, Murray J.

Neurology. 2014 Nov 11;83(20):1789-96. doi: 10.1212/WNL.0000000000000970. Epub 2014 Sep 26.

49.

Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis.

Pittock SJ, Lennon VA, Bakshi N, Shen L, McKeon A, Quach H, Briggs FB, Bernstein AL, Schaefer CA, Barcellos LF.

JAMA Neurol. 2014 Nov;71(11):1433-6. doi: 10.1001/jamaneurol.2014.1581.

PMID:
25178362
50.

Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility.

Flanagan EP, Saito YA, Lennon VA, McKeon A, Fealey RD, Szarka LA, Murray JA, Foxx-Orenstein AE, Fox JC, Pittock SJ.

Neurogastroenterol Motil. 2014 Sep;26(9):1285-97. doi: 10.1111/nmo.12391. Epub 2014 Jul 20.

Supplemental Content

Loading ...
Support Center